Boston Scientific Corporation (BSX)

36.56
NYSE
Prev Close 36.56
Day Low/High 0.00 / 0.00
52 Wk Low/High 24.79 / 39.44
Exchange NYSE
Shares Outstanding 1383.80B
Market Cap 50.02B
Div & Yield N.A. (N.A)
Boston Scientific's Jaw-Dropping Stock Dive Is Buying Opportunity: JPMorgan

Boston Scientific's Jaw-Dropping Stock Dive Is Buying Opportunity: JPMorgan

Shares of the worldwide developer, manufacturer, and marketer of medical devices were sent lower on Tuesday after it delayed the commercialization of its Lotus Edge Aortic Valve System.

Celgene, Bristol-Myers Drop on Poor Earnings as Big Pharma Takes It on the Chin

Celgene, Bristol-Myers Drop on Poor Earnings as Big Pharma Takes It on the Chin

Alexion Pharmaceuticals, Bristol-Myers Squibb and Celgene were among the healthcare firms that unveiled quarterly numbers on Oct. 26.

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Baxter International, Becton Dickinson, Boston Scientific: Cramer's Top Takeaways

Jim Cramer calls Baxter International, Becton Dickinson, and Boston Scientific the 'Killer Bs'.

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

Perils of Politics: Cramer's 'Mad Money' Recap (Monday 7/31/17)

Jim Cramer says he wishes Washington would just focus on repatriation and get a win for the U.S. economy and markets.

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course

This week's bullish and bearish reversal patterns.

Modi's Visit to Meet Trump Focuses Big Spotlight on the H-1B Visa Debate

Modi's Visit to Meet Trump Focuses Big Spotlight on the H-1B Visa Debate

Companies from Amazon to Wipro have a stake in the policies governing tech workers and immigration.

Cramer: These Sectors Look Bullish (Part III)

Cramer: These Sectors Look Bullish (Part III)

From Abbott Labs to Wynn, these names rate checking out.

Cramer: There Are Powerful Themes in Several Bull Markets

Cramer: There Are Powerful Themes in Several Bull Markets

It's a wonder to me how split this market really is.

S&P 500, Dow Hold Slight Gains as Positive Earnings Counter Oil Slump

S&P 500, Dow Hold Slight Gains as Positive Earnings Counter Oil Slump

Stocks hold onto slight to modest gains Thursday afternoon after positive earnings help to offset a slump in crude oil prices and a decline in energy names.

Stocks Turn Mixed in Face of Crude Oil Slump

Stocks Turn Mixed in Face of Crude Oil Slump

Stocks turn mixed on Thursday after a slump in crude oil prices, and a decline in energy names, snarl earlier upward momentum.

Stock Futures Higher as Positive Earnings Offset Weaker Durable Goods Orders

Stock Futures Higher as Positive Earnings Offset Weaker Durable Goods Orders

Stock futures creep higher on Thursday as Wall Street returns its attention to positive earnings for market direction after a day focused on the White House's tax reform plans.

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More

Analysts' Actions -- Amazon, C.R. Bard, CyrusOne, Dow and More

Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical.

Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead

Boston Scientific's Latest Quant Upgrade Reaffirms a Breakout Ahead

A bullish market and another quant upgrade could push BSX past our $31 target.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BSX, RMP, TGEN Downgrades: ESCA, VYGR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock

Canaccord Says Edwards Lifesciences Is Its Favorite Med Tech Stock

Canaccord is bullish on Edwards Lifescience stock.

Cramer: These Stocks Look Like 'Easy Pickings'

Cramer: These Stocks Look Like 'Easy Pickings'

From Aetna to United Technologies, these names are hot.

Cramer: The Best Performers Show No Signs of Letting Up

Cramer: The Best Performers Show No Signs of Letting Up

Their overseas business has been carrying them.

Boston Scientific Confirms $435 Million Purchase of Swiss Co. Symetis

Boston Scientific Confirms $435 Million Purchase of Swiss Co. Symetis

Symetis is a structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ACIW, ACM, BID, CAJ, CHT, GLRE, MBLY, MDXG, UEIC Downgrades: BSX, IAC Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Masimo's Stock Is a Great Buy Right Now

Masimo's Stock Is a Great Buy Right Now

This patient-monitoring device-maker has plenty of room for growth.

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Boston Scientific Corporation And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Boston Scientific Corporation (" Boston Scientific" or the "Company") (NYSE: BSX) concerning possible violations of federal securities...

The S&P 500 Companies With the Most Diverse Boards

The S&P 500 Companies With the Most Diverse Boards

The most ethnically and gender diverse boards may surprise you.

A Play on Intel's Breakdown

A Play on Intel's Breakdown

With trend favoring the bears, I'm favoring a bearish call spread.

Analysts' Actions -- Chipotle, Disney, Brinker, JPMorgan and More

Analysts' Actions -- Chipotle, Disney, Brinker, JPMorgan and More

Here are Tuesday's top research calls, including upgrades for Disney, Continental Resources and Agios Pharmaceuticals, and downgrades for Chipotle, Brinker International and JPMorgan Chase.

Boston Scientific's Upgrade May Lead to Breakout

Boston Scientific's Upgrade May Lead to Breakout

If BSX shares can rise above $24, it's clear sailing to $31, perhaps as soon as next week.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BSX, FCE.B, TEDU Downgrades: ALOG, CCC, EFII, EZPW, NQ, VSTO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Boston Scientific Charts Appear Boston Strong

Boston Scientific Charts Appear Boston Strong

The technical signs indicate the stage may be set for new highs in the maker of medical devices.

Edwards' Life Goes On Without Big M&A

Edwards' Life Goes On Without Big M&A

As the dominant player in the transcatheter aortic valve replacement market, Edwards doesn't 'need' large deals.

How to Trade Wednesday's Most Active Stocks - Sprint, AMD, ArcelorMittal and More

How to Trade Wednesday's Most Active Stocks - Sprint, AMD, ArcelorMittal and More

Here's a technical look on how to trade some of the most active stocks on the market today.

TheStreet Quant Rating: A- (Buy)